Cargando…
Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma
PURPOSE: We aimed to examine the clinical features and prognosis of ocular ischemic syndrome and to investigate the risk factors for the development of neovascular glaucoma (NVG). METHODS: The medical records from 25 patients (25 eyes) who were diagnosed with ocular ischemic syndrome were retrospect...
Autores principales: | Kim, Yung Hui, Sung, Mi Sun, Park, Sang Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540990/ https://www.ncbi.nlm.nih.gov/pubmed/28682017 http://dx.doi.org/10.3341/kjo.2016.0067 |
Ejemplares similares
-
Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009) -
Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
por: Ha, Jun Young, et al.
Publicado: (2017) -
Ocular Decompression Retinopathy after Anterior Chamber Paracentesis for Neovascular Glaucoma
por: Tsai, Yung-En, et al.
Publicado: (2021) -
Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure
por: Senthil, Sirisha, et al.
Publicado: (2021) -
Neovascular Glaucoma from Ocular Ischemic Syndrome Treated with Serial Monthly Intravitreal Bevacizumab and Panretinal Photocoagulation: A Case Report
por: Asif, Hassaan, et al.
Publicado: (2022)